Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Edelmann, Thomas
RAMTAS, NCT03520946 / 2017-004162-99: RAMucirumab in Combination Wth TAS102 vs. TAS102 Alone in Chemotherapy Refractory Metastatic Colorectal Cancer Patients	Active, not recruiting	3	430	Europe	Ramucirumab, TAS 102	Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest, Eli Lilly and Company, Trium Analysis Online GmbH	Colorectal Cancer	12/23	06/24
NCT02131753: Therapy Optimisation for the Treatment of Hairy Cell Leukemia	Recruiting	2/3	210	Europe	Cladribine s.c. injection, HCL treatment, Litak(R), 2-CdA	University of Giessen	Hairy Cell Leukemia	12/25	12/27
Braunert, Leanthe
ITP-Registry, NCT05152238: ITP Registry and Accompanying Biospecimen Collection	Recruiting	N/A	1100	Europe		Jena University Hospital, University Hospital Dresden, Novartis, Swedish Orphan Biovitrum, Grifols Biologicals, LLC, Amgen, argenx	Immune Thrombocytopenia	09/26	04/27